HomeNRXP • NASDAQ
add
NRX Pharmaceuticals Inc
Previous close
$2.34
Day range
$2.36 - $2.51
Year range
$1.15 - $6.01
Market cap
68.84M USD
Avg Volume
467.63K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 242.00K | — |
Operating expense | 4.26M | 41.07% |
Net income | -5.89M | -262.91% |
Net profit margin | -2.43K | — |
Earnings per share | -0.51 | -237.67% |
EBITDA | -4.11M | -36.05% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.18M | 336.45% |
Total assets | 15.00M | 236.08% |
Total liabilities | 40.75M | 75.02% |
Total equity | -25.76M | — |
Shares outstanding | 28.10M | — |
Price to book | -2.52 | — |
Return on assets | -103.81% | — |
Return on capital | 49.90% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -5.89M | -262.91% |
Cash from operations | -2.89M | -25.37% |
Cash from investing | -2.56M | — |
Cash from financing | 9.73M | 373.52% |
Net change in cash | 4.27M | 1,796.03% |
Free cash flow | -5.65M | -1,218.21% |
About
Founded
2015
Headquarters
Website
Employees
2
